Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Manipulation of the alternative NF-kappaB pathway to promote muscle regeneration
EF 2013-14
Résumé
The Nuclear Factor kappaB (NF-kappaB) signaling pathway has been shown to play a critical role in skeletal muscle function as well as muscle recovery following injury. This pathway has also recently been implicated in the pathology of numerous muscle diseases, which include Duchenne's muscular dystrophy (DMD), inflammatory myopathies, and skeletal muscle atrophy. This has led to the NF-kappaB pathway being a potential drug target for these diseases. In our lab, we have recently discovered that the cellular inhibitors of apoptosis, cIAP1 and cIAP2 (genes originally cloned in our laboratory that were shown to have a role in the regulation of cell death) are also involved in NF-kappaB signaling in skeletal muscle. This means that cIAP1/2 are also potential drug targets for muscle diseases where NF-kappaB has been implicated. Furthermore, we have recently found that the TNF-alpha-like weak inducer of apoptosis (TWEAK) protein along with the protein Fn14 are able to regulate the NF-kappaB signalling pathway. In this project, we propose to further investigate this TWEAK/Fn14/cIAP1/NF-kappaB signaling pathway through a genomic approach targeting and suppressing selected genes involved in myogenesis (muscle formation). We hope to thus identify potential downstream mediators or targets of NF-kB signaling which are central to myogenesis, which may help in treating muscle diseases and aiding in muscle regeneration.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311724
Name
Adam Nadine
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Manipulation of the alternative NF-kappaB pathway to promote muscle regeneration
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Fn14 (Tweak Receptor); Inhibitor Of Apoptosis (Ciap1); Myoblast Fusion; Myoblasts; Myogenesis; Myopathy; Nf-Kb Signalling; Rna Interference; Tweak Cytokine
Abstract
The Nuclear Factor kappaB (NF-kappaB) signaling pathway has been shown to play a critical role in skeletal muscle function as well as muscle recovery following injury. This pathway has also recently been implicated in the pathology of numerous muscle diseases, which include Duchenne's muscular dystrophy (DMD), inflammatory myopathies, and skeletal muscle atrophy. This has led to the NF-kappaB pathway being a potential drug target for these diseases. In our lab, we have recently discovered that the cellular inhibitors of apoptosis, cIAP1 and cIAP2 (genes originally cloned in our laboratory that were shown to have a role in the regulation of cell death) are also involved in NF-kappaB signaling in skeletal muscle. This means that cIAP1/2 are also potential drug targets for muscle diseases where NF-kappaB has been implicated. Furthermore, we have recently found that the TNF-alpha-like weak inducer of apoptosis (TWEAK) protein along with the protein Fn14 are able to regulate the NF-kappaB signalling pathway. In this project, we propose to further investigate this TWEAK/Fn14/cIAP1/NF-kappaB signaling pathway through a genomic approach targeting and suppressing selected genes involved in myogenesis (muscle formation). We hope to thus identify potential downstream mediators or targets of NF-kB signaling which are central to myogenesis, which may help in treating muscle diseases and aiding in muscle regeneration.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Adam, Nadine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~